pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2008-0-5-94-100pulmo-1856Research ArticleОБЗОРЫREVIEWК вопросу о применении небулайзерных ингаляций cуспензии будесонида при обострении хронической обструктивной болезни легкихAbout administration of nebulised suspension of budesonide on exacerbation of chronic obstructive pulmonary diseaseЛещенкоИ. В.LeshchenkoI. V.
Екатеринбург
ГОУ ВПО "Уральская государственная медицинская академия"; Медицинское объединение "Новая больница"Russian Federation2008281020080594100Copyright © Лещенко И.В., 20082008Лещенко И.В.Leshchenko I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/1856
.
.
ReferencesGlobal initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (www.goldcopd.com). Date update: November 2006.Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (www.goldcopd.com). Date update: November 2006.Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2007 (www.goldcopd.com).Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2007 (www.goldcopd.com).Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких: Практ. руководство для врачей. 2-е изд. М.; 2004.Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких: Практ. руководство для врачей. 2-е изд. М.; 2004.Сelli B.R., MacNee W., and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS-position paper. Eur. Respir. J. 2004; 23 (6): 932–946.Сelli B.R., MacNee W., and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS-position paper. Eur. Respir. J. 2004; 23 (6): 932–946.Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive disease. Ann. Intern. Med. 1987; 106 (2): 196–204.Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive disease. Ann. Intern. Med. 1987; 106 (2): 196–204.Чучалин А.Г. (ред.). Клинические рекомендации. Хроническая обструктивная болезнь легких. 2-е изд. М.: Атмосфера; 2007.Чучалин А.Г. (ред.). Клинические рекомендации. Хроническая обструктивная болезнь легких. 2-е изд. М.: Атмосфера; 2007.Wood-Baker R.R., Gibson P.G., Hannay M. еt al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Syst. Rev. 2005; 1: CD001288.Wood-Baker R.R., Gibson P.G., Hannay M. еt al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Syst. Rev. 2005; 1: CD001288.Henzen C., Suter A., Lerch E. et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000; 355: 542–545.Henzen C., Suter A., Lerch E. et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000; 355: 542–545.Walsh L.J., Wong C.A., Oborne J. et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001; 56: 279–284.Walsh L.J., Wong C.A., Oborne J. et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001; 56: 279–284.Aaron S.D., Vandemheen K.L., Hebert P. et al. Outpatient oral prednisolone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med. 2003; 348: 2618–2625.Aaron S.D., Vandemheen K.L., Hebert P. et al. Outpatient oral prednisolone after emergency treatment of chronic obstructive pulmonary disease. N. Engl. J. Med. 2003; 348: 2618–2625.Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–852.Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–852.Donaldson G.C., Seemungal T.A., Patel I.S. et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995–2004.Donaldson G.C., Seemungal T.A., Patel I.S. et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995–2004.Wilkinson T.M.A, Donaldson G.C., Hurst J.R. et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 169: 1298–1303.Wilkinson T.M.A, Donaldson G.C., Hurst J.R. et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 169: 1298–1303.Wedzicha J.A., Calverley P.M.A., Seemungal T.A. et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol / fluticasone propionate or tiotropium bromide. Am. J. Respir. Crit. Care Med. 2008; 177: 19–26.Wedzicha J.A., Calverley P.M.A., Seemungal T.A. et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol / fluticasone propionate or tiotropium bromide. Am. J. Respir. Crit. Care Med. 2008; 177: 19–26.Levy M.L., Stevenson C., Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 1996; 51: 1087–1092.Levy M.L., Stevenson C., Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 1996; 51: 1087–1092.Westbroek J., Saarelainen S., Laher M. et al. Oral steroidsparing effect of two doses of nebulized fluticasone and placebo in patients with severe chronic asthma. Respir. Med. 1999; 93: 689–699.Westbroek J., Saarelainen S., Laher M. et al. Oral steroidsparing effect of two doses of nebulized fluticasone and placebo in patients with severe chronic asthma. Respir. Med. 1999; 93: 689–699.Manjra A.I., Price J., Lenney W. et al. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir. Med. 2000; 94: 1206–1214.Manjra A.I., Price J., Lenney W. et al. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir. Med. 2000; 94: 1206–1214.Morice A.H., Morris D., Lawson0Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin. Pharmacol. Ther. 1996; 60: 675–678.Morice A.H., Morris D., Lawson0Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin. Pharmacol. Ther. 1996; 60: 675–678.Maltais F., Ostinelli J., Bourbeau J. et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2002; 165: 698–703.Maltais F., Ostinelli J., Bourbeau J. et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2002; 165: 698–703.Mirici A., Meral M., Akgun M. Comparison of the efficacy of nebulised budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin. Drug Invest. 2003; 23: 55–62.Mirici A., Meral M., Akgun M. Comparison of the efficacy of nebulised budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin. Drug Invest. 2003; 23: 55–62.Авдеев С.Н., Суточникова О.А., Белевский А.С., Чуча0 лин А.Г. Применение небулизированного будесонида при тяжелом обострении хронической обструктивной болезни легких. Рандомизированное контролируемое исследование. Пульмонология 2003; 5: 81–88.Авдеев С.Н., Суточникова О.А., Белевский А.С., Чуча0 лин А.Г. Применение небулизированного будесонида при тяжелом обострении хронической обструктивной болезни легких. Рандомизированное контролируемое исследование. Пульмонология 2003; 5: 81–88.Gunen H., Hacievliyagil S.S., Yetkin O. et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur. Respir. J. 2007; 29: 660–667.Gunen H., Hacievliyagil S.S., Yetkin O. et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur. Respir. J. 2007; 29: 660–667.Marcus P., Oppenheimer E.A., Patel P.A. et al. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Ann. Allergy Asthma Immunol. 2006; 96: 736–743.Marcus P., Oppenheimer E.A., Patel P.A. et al. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Ann. Allergy Asthma Immunol. 2006; 96: 736–743.
The authors declare that there are no conflicts of interest present.